Nanomedicine & Cancer

According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.

    Related Conference of Nanomedicine & Cancer

    September 24-24, 2021

    11th Webinar on Nanotechnology and Nanomedicine

    Paris, France
    October 22-22, 2021

    24th World Nanotechnology Congress

    Rome, Italy
    October 25-26, 2021

    32nd World Nano Conference

    Zurich, Switzerland
    November 01-02, 2021

    38th Global Nanotechnology Congress

    Rome, Italy
    November 15-16, 2021

    35th International Conference on Nanotechnology & Expo

    Madrid, Spain
    December 02-03, 2021

    Applied Nanotechnology Summit

    Tokyo, Japan
    March 21-22, 2022

    39th Global Summit on Nanoscience and Technology

    Tokyo, Japan
    March 25-26, 2022

    18th Nanotechnology and Nanomedicine Congress

    Berlin, Germany
    April 27-28, 2022

    34th Nano Congress for Future Advancements

    Barcelona, Spain
    September 27-28, 2022

    2nd International Conference on Nanomedicine and Drug Delivery

    Bangkok, Thailand

    Nanomedicine & Cancer Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in